Find Academic Supervisors

Valentyn MohylyukView profile

Researcher

• Pharmaceutical Technology
• Drug Delivery Systems
• Formulation Science
• +4 more

Dr. Valentyn Mohylyuk is a pharmaceutical scientist serving as Lead Researcher and Scientific Project Manager at Riga Stradiņš University's pharmaceutical scientific group. He holds a BS/MS in Pharmaceutical Technology and a PhD in Pharmaceutical Science. His career spans academic and industrial roles, including positions at Freie Universität Berlin, University of Hertfordshire, and Queen's University Belfast. His research focuses on formulation science, drug delivery systems, and advanced manufacturing techniques like 3D printing and hot-melt extrusion. Key interests include enhancing drug solubility/bioavailability, developing abuse-deterrent formulations, and continuous manufacturing processes. Education: PhD in Pharmaceutical Science (Year unspecified) BS/MS in Pharmaceutical Technology (Year unspecified) Research Interests: Oral dosage form development with tailored drug release profiles Amorphous solid dispersions and polymer-based formulations 3D printing (FDM) for personalized dosage forms Continuous manufacturing via extrusion and roll compaction Biopharmaceutical permeability studies Articles Trends: Recent work emphasizes 3D printing applications, polymer-drug interactions in amorphous systems, and melt granulation optimization. Key themes include overcoming solubility challenges and advancing manufacturing technologies. Scientific Awards: Letter of Appreciation from the President of the Latvian Academy of Sciences (2024) Grants/Advising: Active projects include sugar alcohol binders in melt granulation (EU-funded) and amorphization mechanisms (Latvian Council) Advising on student projects like solvent effects in solid dispersions Labs/Teams: Leads Riga Stradiņš University's pharmaceutical research group, collaborating internationally on formulation science and advanced manufacturing.

• Orthodontics
• Biomedical Research
• 3D Printing Technology
• +4 more

Oskars Radziņš is a Researcher at the Department of Orthodontics , Riga Stradins University, with expertise in biomedical research, medical imaging, and 3D printing applications. His work bridges orthodontic surgery, pharmaceutical formulation, and artificial intelligence diagnostics. Current projects include 3D-printed oral dosage forms for prednisolone release individualization and AI-driven osteoporosis identification via cone-beam CT. He has contributed to orthognathic surgery outcomes, focusing on soft tissue asymmetry and digital treatment planning precision. Research Trends : His publications highlight interdisciplinary collaboration in biomedical engineering , biomaterials , and machine learning for dental diagnostics. Key subfields include carious lesion detection , excipient optimization , and collagen-based implants . Scientific Awards : Letter of Appreciation from the President of the Latvian Academy of Sciences (2024). Grants & Collaborations : Active in national projects funded by the Latvian Council of Science , including a Biomedical Research Programme and Medical Technology Research Project . Collaborates with experts in AI, pharmacy, and maxillofacial surgery.

Līga PētersoneView profile

Researcher

• Pharmaceutical Chemistry
• Drug Delivery Systems
• Tablet Formulation
• +3 more

Līga Pētersone is a Researcher and Project Manager at Rīga Stradiņš University , focusing on pharmaceutical chemistry and drug delivery systems. She leads innovative projects such as biowaste valorization into health-promoting agents and advanced tablet formulation techniques using polyols. Her research emphasizes solid dosage forms , dissolution testing , and melt granulation , with recent publications in Pharmaceutics and Journal of Pharmaceutical Sciences . She collaborates extensively with researchers like V. Mohylyuk and E. M. Buczkowska. Scientific Awards Letter of Appreciation from the President of the Latvian Academy of Sciences (2024) Līga mentors students such as Žogota, M. , Gurkina, K. , and Mahinovs, R. , and participates in peer-review activities for journals like ACS Sustainable Resource Management and Foods .

Sheng QiView profile

Professor

• Pharmaceutical Materials Science
• Drug Delivery Systems
• Solid-State Characterization
• +5 more

Sheng Qi is a Professor of Pharmaceutical Material Science and Technology at the School of Chemistry, Pharmacy and Pharmacology , University of East Anglia. With a BEng (2001) and PhD (2004) in pharmacy-related fields, her 20-year academic career includes roles from postdoctoral scientist to senior lecturer (2013). She collaborates with global pharmaceutical companies on drug delivery systems, material science, and process engineering. Industrial partnerships with Evonik Industries, Uropharma Ltd, and Innovate UK Editorial role in "3D Printing of Pharmaceutical and Drug Delivery Devices" book Keynote speaker at international conferences since 2013 Research Focus: Fundamental understanding of drug-polymer/lipid dispersions in both solid and liquid states, with emphasis on stabilizing supersaturated drug systems. Her work integrates material science principles with pharmaceutical applications to enhance drug absorption through physical chemistry optimization. Article Trends: Active in 3D printing applications (10+ papers 2021-2024) with focus on shape-memory polymers, polypill design, and geometric release control. Recent work spans anti-pollution cosmetics (2025), implantable drug systems (2023), and advanced characterization techniques like spatial NMR (2025). Awards: 2025 UEA Innovation and Impact Award (Knowledge Exchange Project of the Year) Funding Leadership: Principal Investigator in 8+ projects totaling £1.5M+ since 2009, including INTERREG EU grants and Royal Society awards. Current projects (2023-2025) cover antimicrobial resistance, digital technology training, and personalized medicine. Collaborative Networks: Active in UN Sustainable Development Goals related to health. International collaborations include Germany (Evonik), Czech Republic (Prague workshops), and multiple UK institutions.

Carl A. AndersonView profile

Assistant Professor

• Pharmaceutical Manufacturing
• Process Analytical Technology (PAT)
• Quality by Design (QbD)
• +3 more

Carl A. Anderson is an Assistant Professor of Pharmaceutical Science at Duquesne University's School of Pharmacy. He joined the faculty in 2002 and is a founding member of the Duquesne University Center for Pharmaceutical Technology (DCPT). His research focuses on advancing process analytical technology (PAT), quality by design (QbD), and pharmaceutical manufacturing optimization. Prior to academia, he spent seven years at Aventis Pharmaceuticals, leading teams to develop PAT-based methods for the first PAT-implemented processes in the company. He currently serves on the ASTM E55 committee and previously contributed to revisions of USP standards through the NIR Validation Working Group. Educations: Ph.D., Chemistry, The University of Texas at Austin, 1995 B.S., Chemistry, California State University-Fullerton, 1990 Research Interests: Anderson’s work emphasizes bridging analytical chemistry with pharmaceutical manufacturing challenges. Key areas include PAT tool development, real-time process monitoring, and risk-based quality management systems. His team applies cutting-edge techniques like near-infrared (NIR) spectroscopy and terahertz imaging to enhance understanding of drug formulation physics and chemistry. Grants & Collaborations: 2015: Bristol-Myers Squibb Graduate Student Fellowship (PI) 2015: FDA-funded QbD process development study (Co-PI) 2014: NIPTE-funded training module development (Co-PI) Labs & Teams: Leads the DCPT, a hub for pharmaceutical technology innovation, and collaborates with industry partners like Aventis and Bristol-Myers Squibb. His work integrates academic research with industrial applications, focusing on continuous manufacturing and PAT adoption.

• Molecular Nanotechnology
• Organic Chemistry
• Bioorganic Chemistry
• +3 more

Dr. Christelle Jablonski is a Lecturer in Molecular Life Sciences and Research Associate specializing in nanotechnology and organic chemistry at the FHNW University of Applied Sciences and Arts Northwestern Switzerland. She is affiliated with the School of Life Sciences and the Institute for Chemistry and Bioanalytics in Muttenz. Her research encompasses two primary domains: Molecular Nanotechnology : Focused on bottom-up design of nanomaterials for molecular recognition and (bio)catalysis. Process Engineering & Reaction Technology : Development, pilot testing, and optimization of technical processes for life science industries. Teaching responsibilities include: Bioorganic chemistry (enzymatic reactions, yeast catalysis) for 5th-semester students 1D/2D NMR spectroscopy courses for 3rd, 5th, and 6th semesters Applied organic chemistry in the Master of Science in Life Sciences program Supervision of internships (PCIT, OC) and bachelor/master theses Her publication portfolio spans organic chemistry, nanotechnology, and pharmaceutical sciences, with recent work on nanoparticle synthesis for e-paper, drug delivery systems, and synthetic methodologies in carbohydrate chemistry. Research trends show consistent focus on stereoselective synthesis, functional materials, and reaction mechanism elucidation. No scientific awards are mentioned in the source material. She advises bachelor/master thesis students and contributes to the Institute for Chemistry and Bioanalytics research teams, including nanotechnology and process engineering groups.

Georg LippsView profile

Professor

• Protein Engineering
• Biochemistry
• Biotechnology
• +4 more

Prof. Georg Lipps is a faculty member at FHNW University of Applied Sciences in Switzerland, serving as Dean of the MSc in Life Sciences program and Team Leader of the Proteins and Enzymes research group. His primary affiliation is with the School of Life Sciences and the Institute for Chemistry and Bioanalytics. His career includes roles as Assistant Professor (2004-2007) and Substitute Professor (2007-2008) at the University of Bayreuth, Germany, and research positions in biochemistry and enzyme engineering. Education: Vordiplom (Bachelor) in Biology, University of Münster (1989) Diplom (Master) in Biochemistry, University of Witten-Herdecke (1992) PhD in Biochemistry, University of Giessen (1994) Habilitation in Biochemistry, University of Bayreuth (2004) Research Interests: Focuses on protein engineering, enzyme optimization for biotechnological applications, archaeal genetics (e.g., Sulfolobus species), and drug delivery systems. His work bridges fundamental biochemistry with applied research in thermostable enzymes and colonic drug delivery mechanisms. Grants & Collaborations: SNF grants for primase structure/function studies (2004–2023) CTI grants for enzyme-based drug development (2016–2023) Collaborations with institutions like ETH Zurich and DSM Nutritional Products Labs/Teams: Leads the Proteins and Enzymes team at FHNW, specializing in enzyme engineering and archaeal molecular biology. Active in interdisciplinary projects involving pharmaceutical and biotechnological applications.

• Archaeometry
• Material Science
• Computed Tomography
• +3 more

Samaneh Ehteram is a Researcher affiliated with the Cluster of Excellence ‘Understanding Written Artefacts’ (UWA) at the University of Hamburg. She holds a Master of Arts and works in the Artefact Profiling department. Her research focuses on non-invasive material analysis of ancient artifacts using advanced technologies like XRF spectroscopy, Raman spectroscopy, and computed tomography (CT). She is involved in projects such as reading closed cuneiform tablets using high-resolution CT and developing additive-free nanoinks for 3D printing aerogels. Ehteram’s work bridges archaeology, materials science, and digital preservation. Projects: Reading Closed Cuneiform Tablets Using High-Resolution CT (2020–2025), Material Analysis of Egyptian Shabtis, and aerogel synthesis. Affiliations: DESY (office: Room 94) and University of Hamburg’s Warburgstraße 26 campus. Her contributions include peer-reviewed publications in journals like Advanced Functional Materials and conference presentations on archaeometric techniques. She collaborates with multidisciplinary teams in cultural heritage preservation and materials engineering.

• Pharmaceutical Sciences
• Drug Stability
• Medication Adherence
• +3 more

Sherryl G. Robertson is a researcher affiliated with James Cook University's College of Medicine and Dentistry , School of Pharmacy. Her work focuses on pharmaceutical stability, medication adherence, and formulation science, particularly in tropical environments. Her research interests include: Ensuring chemical and physical stability of medications repackaged into dose administration aids (DAAs) Assessing substandard drug products in developing regions Developing analytical methods for UV filter compounds in sunscreens Pharmacokinetic studies of antifungal treatments Key trends in her publications show expertise in tropical pharmaceutical challenges, medication management, and UV protection chemistry. Her collaborations with Beverley D. Glass and others span 2002–2022, covering journals like Pharmaceutics , American Journal of Tropical Medicine and Hygiene , and Journal of Photochemistry and Photobiology C: Photochemistry Reviews .

• Micro-scale drug delivery
• 3-D printing of pharmaceuticals
• Microneedle transdermal systems
• +4 more

Associate Professor Lifeng Kang is a pharmaceutical scientist at the University of Sydney School of Pharmacy , Faculty of Medicine and Health. He leads the Kang Lab which develops micro-scale and 3-D-printing technologies for drug delivery and regenerative medicine, and teaches undergraduate and postgraduate pharmacy courses. Education & career: BSc & MSc – China Pharmaceutical University (Nanjing, China) PhD – National University of Singapore (2006, drug delivery) Post-doctoral fellow – Massachusetts Institute of Technology (2007-2009, NUS-OPF Fellowship) Lecturer & Programme Director – National University of Singapore (2009-2017) Lecturer → Senior Lecturer → Associate Professor – University of Sydney (2017-present) Visiting Scholar – Stanford University (2019) Research focus: Microfabricated drug-delivery systems, 3-D printing of personalised medicines, dissolvable and hydrogel-forming microneedles, transdermal vaccination and cosmeceuticals, silk-fibroin and peptide biomaterials, organoid models for toxicology, and machine-learning-guided formulation design. Publications & impact: 86 peer-reviewed articles (65 first/corresponding), >4,600 citations, H-index 40, listed in Stanford/Elsevier global top-2 % scientists 2022-2024. Recent work appears in Nature Nanotechnology , Advanced Drug Delivery Reviews , Journal of Controlled Release , Analytical Chemistry and Biomaterials Advances . Innovation & translation: 10 patent families (5 granted, 3 licensed to industry); doctoral students have spun out two start-ups in 3-D-printed pharmaceuticals and microneedle devices. Current grants target osteoarthritis pain, skin depigmentation, paediatric IV stability and needle-free vaccination. Leadership & service: Vice-Chair (ANZ) Dissolution Research Presentation International 2023; 2nd-Year BPharm Coordinator; editorial boards of Advanced Drug Delivery Reviews , Frontiers in Pharmacology , Journal of Pharmacy and Pharmacology , Nano Convergence and others; reviewer for 40+ journals. Teaching & supervision: 14 years’ experience, primary supervisor of 15 PhD/MPhil students and >50 honours/project students; teaches drug delivery, formulation science and pharmaceutical analysis; research interest in mastery learning and formative assessment.

Karen HapgoodView profile

Professor

• Chemical Engineering
• Pharmaceutical Manufacturing
• Minerals Processing
• +3 more

Professor Karen Hapgood is the Deputy Vice-Chancellor, Research at Swinburne University of Technology. She leads research strategy and partnerships, with over 20 years of academic and industry experience in chemical engineering, pharmaceutical manufacturing, and minerals processing. Previously, she held leadership roles including Executive Dean at Deakin University's Faculty of Science Engineering and Built Environment, and Dean of Engineering at Deakin. Education: PhD (Chemical Engineering) and BE (Chemical Engineering, First Class Honours) from the University of Queensland. She is a Fellow of ATSE, IChemE, RACI, and Engineers Australia, and a Graduate of the Australian Institute of Company Directors. Research focuses on wet granulation, pharmaceutical formulation, additive manufacturing, and mineral processing. Notable grants include Australian Research Council projects on particle breakage modeling, powder inhaler design, and antisolvent vapor spray drying systems. Awards highlight her expertise and leadership: Fellowships in multiple engineering societies, and recognition for advancing diversity in STEM. She actively supervises PhD research in pharmaceutical and materials engineering.

• Nanoparticle Drug Delivery Systems
• Stem Cell Biology
• Metabolomics
• +5 more

Mohammad Al-Natour, PhD is a Postdoctoral Research Scholar at the University of Iowa's College of Pharmacy, affiliated with the Department of Pharmaceutical Sciences and Experimental Therapeutics. His research focuses on nanoparticle design for drug delivery, stem cell biology, and metabolomics analysis in biomedical applications. Dr. Al-Natour holds a PhD in Pharmaceutical Sciences. His work integrates nanotechnology, biomaterials science, and analytical techniques like LC-MS/MS to investigate drug delivery mechanisms, cellular responses to nanoparticles, and metabolic pathways in disease models. His research interests include: Development of targeted nanomedicines for cancer therapy Stem cell interactions with engineered biomaterials Metabolomics-based evaluation of nanoparticle toxicity Optimization of polymer-based drug delivery systems Publications highlight trends in: Nanoparticle surface functionalization for targeted drug delivery Metabolomic profiling of cellular responses to therapeutics Biomaterial design for dental and regenerative medicine applications Preclinical evaluation of drug-nanoparticle interactions No scientific awards or grants are listed in his profile. His work contributes to advancing translational nanomedicine and drug delivery technologies.

• Pharmaceutics
• Drug Delivery Systems
• Pharmaceutical Formulation
• +3 more

Professor Abina Crean is a faculty member at the School of Pharmacy , University College Cork , Ireland. With a PhD in Pharmaceutics from Trinity College Dublin, she established a pharmaceutical technology research group at UCC in 2003 and leads projects in pharmaceutical manufacturing, formulation science, and biopharmaceutical delivery systems. BSc Pharmacy, Robert Gordon's University PhD Pharmaceutics, Trinity College Dublin Her research focuses on pharmaceutical excipients , solid oral dosage forms , microneedle systems , and oral bioavailability enhancement . She actively collaborates with pharmaceutical companies and contributes to SFI's SSPC (Science Foundation Ireland Pharmaceutical Research Centre). Recent publications analyze protein stability in microneedles , insulin degradation , excipient behavior , and continuous manufacturing . Her group explores biorelevant testing , quality-by-design strategies , and patient-centric formulations for children and elderly populations. Key collaborations include industry partnerships and academic contributions to European Journal of Pharmaceutics , Molecular Pharmaceutics , and Drug Delivery and Translational Research . She supervises PhD/MSc students in pharmaceutical technology and biopharmaceutical processing .

Daniel KirbyView profile

Senior Lecturer

• Pharmaceutics
• Drug Delivery
• Pediatric and Geriatric Medicines
• +6 more

Daniel Kirby is a Senior Lecturer and Head of Pharmaceutical Sciences at Aston Pharmacy School, part of the College of Health and Life Sciences at Aston University. He has held academic roles since 2010, including his current leadership role since 2023. His research focuses on developing age-appropriate drug formulations for pediatric and geriatric populations, with a particular emphasis on polymer-based systems, 3D-printed dosage forms, and taste-masking technologies. He also leads initiatives in extemporaneous formulation to address gaps in commercially available medications for vulnerable demographics. Education: BSc in Combined Honours Chemistry and French (Aston University, 2003) PhD in Pharmaceutics/Drug Delivery (Aston University, 2007) Postgraduate Certificate in Professional Practice in Higher Education (Aston University, 2015) Research Interests: His work integrates patient-centric design principles with advanced pharmaceutical technologies, including orally disintegrating tablets, lipid-based delivery systems, and 3D printing applications. Current projects address pediatric-specific challenges such as dosage form stability, palatability, and adherence. Professional Contributions: He holds roles on the British Pharmacopoeia Expert Advisory Group on Unlicensed Medicines and the Academy of Pharmaceutical Sciences’ Age Related Medicines focus group. His peer-review activities include contributions to journals like the International Journal of Pharmaceutics and Journal of Liposome Research . Awards: Fellow of the Higher Education Academy Teaching and Supervision: Leads courses on enteral drug delivery and pharmaceutical calculations. Currently accepting self-funded PhD students in pharmaceutics and drug delivery. Labs/Teams: Active in the Pharmaceutical & Clinical Pharmacy Research Group (PCPRG), focusing on translational research in pediatric and geriatric drug formulation.

Stephen KellyView profile

Senior Lecturer

• Medieval Studies
• Contemporary Literary Theory
• Philosophical Hermeneutics
• +6 more

Stephen Kelly is a Senior Lecturer at Queen's University Belfast's School of Arts, English and Languages, specializing in medieval literature, digital humanities, and philosophical hermeneutics. He has held leadership roles including Director of Education (2024–present), Head of English (2016–2022), and Director of the Institute for Collaborative Research in the Humanities (2013–2014). His research explores late medieval religious texts, historiography, and digital textualities, supported by grants like the Leverhulme Trust's Whittington’s Gift project (2020–2024). He has supervised over 20 PhD students and received teaching awards in 2016 and 2019. Education: PhD from Queen's University Belfast (1998). Previous positions: Lecturer at University of Kent (post-PhD) and postdoctoral fellow on the Imagining History project (2003–2006). Research interests include medieval literature, digital humanities, and translation theory. He co-leads projects like the Geographies of Orthodoxy (AHRC-funded, 2007–2010) and has published extensively in medieval studies and contemporary theory. His work intersects with visual studies, cultural theory, and collaborative digital initiatives. Recent articles focus on antibiotic resistance mechanisms, microbial communities, and drug delivery systems, reflecting interdisciplinary collaborations. Awards include the Queen's University Teaching Award (2019) and external examiner roles at Trinity College Dublin and the University of Huddersfield. His advisory work spans medieval literary studies, with notable supervisees in areas like Flann O’Brien's work, John Dee's identities, and late medieval Lynn's virtues. He teaches courses on critical theory, research methods, and the history of ideas.